The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians

@inproceedings{Bakirtzis2018TheRF,
  title={The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians},
  author={Christos Bakirtzis and Panagiotis Ioannidis and Lambros Messinis and Grigorios Nasios and Elina Konstantinopoulou and Panagiotis Papathanasopoulos and Nikolaos Grigoriadis},
  booktitle={The open neurology journal},
  year={2018}
}
About half of patients with multiple sclerosis exhibit cognitive impairment which negatively affects their quality of life. The assessment of cognitive function in routine clinical practice is still undervalued, although various tools have been proposed for this reason. In this article, we describe the potential benefits of implementing cognitive assessment tools in routine follow -ups of MS patients. Early detection of changes in cognitive performance may provide evidence of disease activity… CONTINUE READING

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 98 REFERENCES

MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.

  • Journal of neurology, neurosurgery, and psychiatry
  • 2016
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Cognitive impairment in multiple sclerosis – recent advances and future prospects

DW Langdon
  • Eur Neurol Rev 2010;
  • 2010
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Association Between Cognitive Complaints and Vulnerability to Environmental Distraction in Multiple Sclerosis.

  • Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
  • 2017
VIEW 2 EXCERPTS